(RACE) Ferrari - Overview
Exchange: NYSE •
Country: Italy •
Currency: USD •
Type: Common Stock •
ISIN: NL0011585146
Stock: Sports Cars, Supercars, Engines, Parts
Total Rating 48
Risk 92
Buy Signal -1.55
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.48% |
| Yield on Cost 5y | 3.28% |
| Yield CAGR 5y | 58.55% |
| Payout Consistency | 98.2% |
| Payout Ratio | 96.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 28.0% |
| Relative Tail Risk | -6.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.91 |
| Alpha | -37.07 |
| Character TTM | |
|---|---|
| Beta | 0.708 |
| Beta Downside | 0.440 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.19% |
| CAGR/Max DD | 0.25 |
Description: RACE Ferrari January 29, 2026
Ferrari N.V. designs, engineers, manufactures and sells ultra-luxury performance automobiles-including sports, track, one-off and supercars-while also monetising the brand through spare-parts sales, after-sales services, licensing of luxury goods, museum and hospitality venues, and a suite of financing and leasing solutions.
In FY 2023 the company reported €4.5 billion of revenue, a net profit of €904 million and delivered 13,037 cars, yielding an average transaction price of roughly €250 k per vehicle-both revenue and profit margins remaining among the highest in the global automotive sector.
Key drivers of Ferrari’s outlook include sustained demand from high-net-worth consumers in North America, Europe and China, a relatively inelastic luxury-car market, and the firm’s strategic push toward hybrid and fully electric models to meet tightening EU emissions regulations while preserving its performance DNA.
For a deeper, data-rich assessment of how these factors translate into valuation metrics, you may find ValueRay’s analytical platform worth exploring.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 1.60b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 3.76 > 1.0 |
| NWC/Revenue: 37.90% < 20% (prev 27.49%; Δ 10.41% < -1%) |
| CFO/TA 0.25 > 3% & CFO 2.33b > Net Income 1.60b |
| Net Debt (1.45b) to EBITDA (2.63b): 0.55 < 3 |
| Current Ratio: 2.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (178.3m) vs 12m ago -0.83% < -2% |
| Gross Margin: 51.26% > 18% (prev 0.50%; Δ 5077 % > 0.5%) |
| Asset Turnover: 76.66% > 50% (prev 71.91%; Δ 4.75% > 0%) |
| Interest Coverage Ratio: 46.59 > 6 (EBITDA TTM 2.63b / Interest Expense TTM 44.5m) |
Altman Z'' 5.32
| A: 0.28 (Total Current Assets 4.74b - Total Current Liabilities 2.06b) / Total Assets 9.48b |
| B: 0.39 (Retained Earnings 3.67b / Total Assets 9.48b) |
| C: 0.22 (EBIT TTM 2.07b / Avg Total Assets 9.24b) |
| D: 0.66 (Book Value of Equity 3.77b / Total Liabilities 5.71b) |
| Altman-Z'' Score: 5.32 = AAA |
Beneish M -3.10
| DSRI: 0.96 (Receivables 1.94b/1.84b, Revenue 7.08b/6.46b) |
| GMI: 0.97 (GM 51.26% / 49.80%) |
| AQI: 0.99 (AQ_t 0.29 / AQ_t-1 0.29) |
| SGI: 1.10 (Revenue 7.08b / 6.46b) |
| TATA: -0.08 (NI 1.60b - CFO 2.33b) / TA 9.48b) |
| Beneish M-Score: -3.10 (Cap -4..+1) = AA |
What is the price of RACE shares?
As of February 06, 2026, the stock is trading at USD 334.76 with a total of 452,204 shares traded.
Over the past week, the price has changed by -1.09%, over one month by -11.74%, over three months by -17.68% and over the past year by -26.80%.
Over the past week, the price has changed by -1.09%, over one month by -11.74%, over three months by -17.68% and over the past year by -26.80%.
Is RACE a buy, sell or hold?
Ferrari has received a consensus analysts rating of 3.92.
Therefore, it is recommended to buy RACE.
- StrongBuy: 5
- Buy: 3
- Hold: 4
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the RACE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 455.1 | 36% |
| Analysts Target Price | 455.1 | 36% |
| ValueRay Target Price | 328.5 | -1.9% |
RACE Fundamental Data Overview February 05, 2026
Market Cap EUR = 49.56b (58.51b USD * 0.847 USD.EUR)
P/E Trailing = 31.2507
P/E Forward = 29.5858
P/S = 8.2645
P/B = 13.3233
P/EG = 3.9293
Revenue TTM = 7.08b EUR
EBIT TTM = 2.07b EUR
EBITDA TTM = 2.63b EUR
Long Term Debt = 1.81b EUR (from longTermDebt, last quarter)
Short Term Debt = 930.6m EUR (from shortTermDebt, last quarter)
Debt = 2.88b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.45b EUR (from netDebt column, last quarter)
Enterprise Value = 50.90b EUR (49.56b + Debt 2.88b - CCE 1.54b)
Interest Coverage Ratio = 46.59 (Ebit TTM 2.07b / Interest Expense TTM 44.5m)
EV/FCF = 34.63x (Enterprise Value 50.90b / FCF TTM 1.47b)
FCF Yield = 2.89% (FCF TTM 1.47b / Enterprise Value 50.90b)
FCF Margin = 20.76% (FCF TTM 1.47b / Revenue TTM 7.08b)
Net Margin = 22.63% (Net Income TTM 1.60b / Revenue TTM 7.08b)
Gross Margin = 51.26% ((Revenue TTM 7.08b - Cost of Revenue TTM 3.45b) / Revenue TTM)
Gross Margin QoQ = 50.05% (prev 52.64%)
Tobins Q-Ratio = 5.37 (Enterprise Value 50.90b / Total Assets 9.48b)
Interest Expense / Debt = 0.20% (Interest Expense 5.78m / Debt 2.88b)
Taxrate = 22.00% (107.7m / 489.4m)
NOPAT = 1.62b (EBIT 2.07b * (1 - 22.00%))
Current Ratio = 2.30 (Total Current Assets 4.74b / Total Current Liabilities 2.06b)
Debt / Equity = 0.76 (Debt 2.88b / totalStockholderEquity, last quarter 3.77b)
Debt / EBITDA = 0.55 (Net Debt 1.45b / EBITDA 2.63b)
Debt / FCF = 0.99 (Net Debt 1.45b / FCF TTM 1.47b)
Total Stockholder Equity = 3.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.35% (Net Income 1.60b / Total Assets 9.48b)
RoE = 44.44% (Net Income TTM 1.60b / Total Stockholder Equity 3.60b)
RoCE = 38.29% (EBIT 2.07b / Capital Employed (Equity 3.60b + L.T.Debt 1.81b))
RoIC = 24.40% (NOPAT 1.62b / Invested Capital 6.62b)
WACC = 8.06% (E(49.56b)/V(52.44b) * Re(8.52%) + D(2.88b)/V(52.44b) * Rd(0.20%) * (1-Tc(0.22)))
Discount Rate = 8.52% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.70%
[DCF Debug] Terminal Value 81.06% ; FCFF base≈1.30b ; Y1≈1.61b ; Y5≈2.74b
Fair Price DCF = 249.9 (EV 45.73b - Net Debt 1.45b = Equity 44.27b / Shares 177.1m; r=8.06% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 88.72 | EPS CAGR: 17.74% | SUE: 0.96 | # QB: 1
Revenue Correlation: 97.37 | Revenue CAGR: 11.56% | SUE: 0.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.42 | Chg30d=+0.002 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=9.56 | Chg30d=-0.113 | Revisions Net=-4 | Growth EPS=+6.8% | Growth Revenue=+5.7%
P/E Trailing = 31.2507
P/E Forward = 29.5858
P/S = 8.2645
P/B = 13.3233
P/EG = 3.9293
Revenue TTM = 7.08b EUR
EBIT TTM = 2.07b EUR
EBITDA TTM = 2.63b EUR
Long Term Debt = 1.81b EUR (from longTermDebt, last quarter)
Short Term Debt = 930.6m EUR (from shortTermDebt, last quarter)
Debt = 2.88b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.45b EUR (from netDebt column, last quarter)
Enterprise Value = 50.90b EUR (49.56b + Debt 2.88b - CCE 1.54b)
Interest Coverage Ratio = 46.59 (Ebit TTM 2.07b / Interest Expense TTM 44.5m)
EV/FCF = 34.63x (Enterprise Value 50.90b / FCF TTM 1.47b)
FCF Yield = 2.89% (FCF TTM 1.47b / Enterprise Value 50.90b)
FCF Margin = 20.76% (FCF TTM 1.47b / Revenue TTM 7.08b)
Net Margin = 22.63% (Net Income TTM 1.60b / Revenue TTM 7.08b)
Gross Margin = 51.26% ((Revenue TTM 7.08b - Cost of Revenue TTM 3.45b) / Revenue TTM)
Gross Margin QoQ = 50.05% (prev 52.64%)
Tobins Q-Ratio = 5.37 (Enterprise Value 50.90b / Total Assets 9.48b)
Interest Expense / Debt = 0.20% (Interest Expense 5.78m / Debt 2.88b)
Taxrate = 22.00% (107.7m / 489.4m)
NOPAT = 1.62b (EBIT 2.07b * (1 - 22.00%))
Current Ratio = 2.30 (Total Current Assets 4.74b / Total Current Liabilities 2.06b)
Debt / Equity = 0.76 (Debt 2.88b / totalStockholderEquity, last quarter 3.77b)
Debt / EBITDA = 0.55 (Net Debt 1.45b / EBITDA 2.63b)
Debt / FCF = 0.99 (Net Debt 1.45b / FCF TTM 1.47b)
Total Stockholder Equity = 3.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.35% (Net Income 1.60b / Total Assets 9.48b)
RoE = 44.44% (Net Income TTM 1.60b / Total Stockholder Equity 3.60b)
RoCE = 38.29% (EBIT 2.07b / Capital Employed (Equity 3.60b + L.T.Debt 1.81b))
RoIC = 24.40% (NOPAT 1.62b / Invested Capital 6.62b)
WACC = 8.06% (E(49.56b)/V(52.44b) * Re(8.52%) + D(2.88b)/V(52.44b) * Rd(0.20%) * (1-Tc(0.22)))
Discount Rate = 8.52% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.70%
[DCF Debug] Terminal Value 81.06% ; FCFF base≈1.30b ; Y1≈1.61b ; Y5≈2.74b
Fair Price DCF = 249.9 (EV 45.73b - Net Debt 1.45b = Equity 44.27b / Shares 177.1m; r=8.06% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 88.72 | EPS CAGR: 17.74% | SUE: 0.96 | # QB: 1
Revenue Correlation: 97.37 | Revenue CAGR: 11.56% | SUE: 0.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.42 | Chg30d=+0.002 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=9.56 | Chg30d=-0.113 | Revisions Net=-4 | Growth EPS=+6.8% | Growth Revenue=+5.7%